Alterations in the Intestinal Microbiota in ASD: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:
Jose Enrique de la Rubia Ortí
,
Costanza Moneti
,
Pilar Serrano-Ballesteros
,
Gloria Castellano
,
Raquel Bayona-Babiloni
,
Ana Belén Carriquí-Suárez
,
María Motos-Muñoz
,
Belén Proaño
,
María Benlloch

Autism Spectrum Disorder (ASD) is characterized by varying degrees of difficulty in social interaction and communication. These deficits are often associated with gastrointestinal symptoms, indicating alterations in both intestinal microbiota composition and metabolic activities. The intestinal microbiota influences the function and development of the nervous system.

  • Autism Spectrum Disorder (ASD)
  • microbiota
  • epigallocatechin-3-gallate (EGCG)

1. Introduction

Autism Spectrum Disorder (ASD) is a highly heterogeneous and complex disorder characterized by two major groups of core symptoms: (1) persistent deficits in social communication and interaction and (2) restricted and repetitive patterns of behavior, interests, or activities [1][2][3][4][5]. Current epidemiology statistics indicate that the disorder affects approximately 1 in every 160 children worldwide [6].
Characteristic deficits are often associated with a range of gastrointestinal symptoms such as abdominal pain, diarrhea, or constipation [7][8]. Several studies have found that both the composition of the intestinal microbiota and metabolic activities may be altered in individuals with the disorder ASD [9][10]. Therefore, several authors concur that disruptions in the microbiota and intestinal microbiome, i.e., the collection of microorganisms present in the human gastrointestinal tract and their respective genomes [3][11], could trigger many of the gastrointestinal issues experienced by children with ASD, as well as exacerbate some of the core symptoms of the disorder [12][13].
Microbial colonization begins in infancy via the acquisition of maternal microbiota during vaginal delivery [3]. Subsequently, beneficial microorganisms feed on breast milk, which has a high content of oligosaccharides [14]. Similarly, the composition of the microbiota in the early years may be subject to alterations influenced by the delivery method, hygiene habits, and feeding practices and routines. Among these factors, formula feeding has a particularly significant impact [3].
It has been shown that the intestinal microbiota affects the function and development of the immune, metabolic, and nervous systems. Regarding the immune and metabolic systems, intestinal microbiota and its metabolites impact host physiology by regulating the function of the intestinal barrier, redox and mitochondrial metabolism, and mucosal inflammatory response via the regulation of intestinal lymphocytes that provide resistance against potential pathogens [15][16][17][18][19][20]. On the other hand, intestinal microbiota can influence neurochemistry, function, gene expression, and the development of the central nervous system (CNS) through the gut–brain axis, which represents a bidirectional link between the cognitive and emotional functions of the CNS and peripheral intestinal function [15][21][22][23]. It is worth noting that the genus Bifidobacterium can metabolize gamma-aminobutyric acid (GABA), Lactobacillus spp. can metabolize acetylcholine, Bacillus spp. and Serratia spp., dopamine, and Escherichia spp. and Saccharomyces spp., noradrenaline. All these neurotransmitters are essential for the proper functioning of the nervous system as they can enter circulation and directly affect neural processes throughout the body, including the brain [3][24]. Additionally, intestinal proinflammatory cytokines, particularly TNF and IL-6, can have an impact on the brain because they make the blood–brain barrier (BBB) more permeable, allowing peripheral immune cells to enter the brain and stimulating brain cells to produce additional proinflammatory mediators [25][26].
All of this has led to the hypothesis that the development of symptoms related to ASD may be influenced by the disturbance of the gut–brain–microbiota axis caused by changes in the intestinal microbiota. ASD is a complex disorder characterized by inflammatory processes, high oxidative stress, and gastrointestinal disturbances. These issues may be attributed to changes in the intestinal microbiome, resulting in microbial dysbiosis in children with ASD. Polyphenols have demonstrated sufficient antioxidant and anti-inflammatory capacity to counteract ASD symptoms.

2. Alterations in the Intestinal Microbiota in ASD

The Firmicutes (40–60%) and Bacteroidetes (20–40%) are the two major phyla of bacteria in the healthy human intestinal flora, followed by Proteobacteria, Actinomycetes, Clostridium spp., and Verruciformis [3][27]. However, compared to a healthy population, increased levels of bacterial genera such as Clostridium, Desulfovibrio, and Ruminococcus have been observed [15][28], in ASD, along with species that synthesize BCAA such as Bacteroides vulgatus and Prevotella copri. On the other hand, lower quantities of Bacteroides fragilis, Akkermansia muciniphila, Bifidobacterium spp., and Enterococcus spp. Have been found [29][30]. Additionally, the ratio of the Escherichia/Shigella genera is altered, as Shigella spp. is present at higher levels, while Escherichia coli is decreased [31].
It should be noted that, despite the consensus regarding these alterations, it is important to consider that not all studies quantifying the microbiota in ASD analyze the same species or genera, leading to some heterogeneity in the results, and various studies emphasize the relationship between the composition of the human intestinal microbiota and the individual’s diet, which can lead to variations in composition depending on the region where the analyses were conducted [32]. In fact, a study in the United States highlighted that children with ASD had lower levels of Bifidobacterium spp. And Prevotella spp., but higher levels of Lactobacillus spp., compared to healthy children [33]. Another study in China described that children with ASD had higher levels of the Actinobacteria and Proteobacteria phyla than the control group [34].
Furthermore, the review conducted by Ho et al. (2020) concluded that although the results of different studies are not entirely consistent [35], some articles indicate that individuals with ASD exhibit a decrease in the percentage of the phylum Bacteroidetes [10][35] or no significant difference [31][36][37] compared to the control group of healthy individuals. This could be due to the fact that within the phylum Bacteroidetes, there are bacteria of the genus Bacteroides spp. that are increased, such as B. vulgatus, while others are decreased, such as B. fragilis, potentially leading to a compensatory effect that results in an unclear profile [30].
The genus Prevotella presents a more variable pattern. In the aforementioned review, the authors noted a lower relative abundance of Prevotella spp. in children diagnosed with ASD compared to the control group. However, multiple studies indicate an elevated prevalence of Prevotella spp. in children with ASD [15][30][31][38], and this variability could be due to dietary factors. Filippo et al. (2010) compared the composition of Prevotella spp. in the microbiota of children following European and African diets and observed a significant increase in Prevotella spp. In the microbiota of African children, likely due to their consumption of a grain-rich diet [39].
Finally, to establish a correlation between gastrointestinal issues and behavioral problems with the microbiota, the high growth rates of Clostridium histolyticum, Clostridium difficile, Clostridium perfringens, and Sutterella spp., the alteration in the Escherichia/Shigella genera ratio, and the decreased Bacteroidetes/Firmicutes phylum ratio have been identified as factors associated with gastrointestinal problems. Furthermore, the relative abundance of Desulfovibrio spp., Clostridium spp., and Bacteroides vulgatus has been linked to behavioral disorders [40].

This entry is adapted from the peer-reviewed paper 10.3390/nu15143265

References

  1. Taylor, M.J.; Rosenqvist, M.A.; Larsson, H.; Gillberg, C.; D’Onofrio, B.M.; Lichtenstein, P.; Lundström, S. Etiology of Autism Spectrum Disorders and Autistic Traits Over Time. JAMA Psychiatry 2020, 77, 936–943.
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5 th ed.; 2013; American Psychiatric Association: Washington, DC, USA; Available online: https://dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596 (accessed on 18 May 2013).
  3. Hughes, H.K.; Rose, D.; Ashwood, P. The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders. Curr. Neurol. Neurosci. Rep. 2018, 18, 81.
  4. Maenner, M.J.; Warren, Z.; Williams, A.R.; Amoakohene, E.; Bakian, A.V.; Bilder, D.A.; Durkin, M.S.; Fitzgerald, R.T.; Furnier, S.M.; Hughes, M.M.; et al. Prevalence and Characteristics of Autism Spectrum Disorder among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill. Summ. 2023, 72, 1–14.
  5. Grimaldi, R.; Gibson, G.R.; Vulevic, J.; Giallourou, N.; Castro-Mejía, J.L.; Hansen, L.H.; Leigh Gibson, E.; Nielsen, D.S.; Costabile, A. A Prebiotic Intervention Study in Children with Autism Spectrum Disorders (ASDs). Microbiome 2018, 6, 133.
  6. World Health Organization. Autism. Available online: https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders (accessed on 26 February 2023).
  7. Li, Q.; Zhou, J.M. The Microbiota–Gut–Brain Axis and Its Potential Therapeutic Role in Autism Spectrum Disorder. Neuroscience 2016, 324, 131–139.
  8. Yang, J.; Fu, X.; Liao, X.; Li, Y. Effects of Gut Microbial-Based Treatments on Gut Microbiota, Behavioral Symptoms, and Gastrointestinal Symptoms in Children with Autism Spectrum Disorder: A Systematic Review. Psychiatry Res. 2020, 293, 113471.
  9. de Theije, C.G.M.; Wopereis, H.; Ramadan, M.; van Eijndthoven, T.; Lambert, J.; Knol, J.; Garssen, J.; Kraneveld, A.D.; Oozeer, R. Altered Gut Microbiota and Activity in a Murine Model of Autism Spectrum Disorders. Brain Behav. Immun. 2014, 37, 197–206.
  10. Strati, F.; Cavalieri, D.; Albanese, D.; De Felice, C.; Donati, C.; Hayek, J.; Jousson, O.; Leoncini, S.; Renzi, D.; Calabrò, A.; et al. New Evidences on the Altered Gut Microbiota in Autism Spectrum Disorders. Microbiome 2017, 5, 24.
  11. Huttenhower, C.; Gevers, D.; Knight, R.; Abubucker, S.; Badger, J.H.; Chinwalla, A.T.; Creasy, H.H.; Earl, A.M.; Fitzgerald, M.G.; Fulton, R.S.; et al. Structure, Function and Diversity of the Healthy Human Microbiome. Nature 2012, 486, 207–214.
  12. Rinninella, E.; Raoul, P.; Cintoni, M.; Franceschi, F.; Miggiano, G.A.D.; Gasbarrini, A.; Mele, M.C. What Is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 2019, 7, 14.
  13. Iovene, M.R.; Bombace, F.; Maresca, R.; Sapone, A.; Iardino, P.; Picardi, A.; Marotta, R.; Schiraldi, C.; Siniscalco, D.; Serra, N.; et al. Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders. Mycopathologia 2017, 182, 349–363.
  14. Yadav, M.; Kapoor, A.; Verma, A.; Ambatipudi, K. Functional Significance of Different Milk Constituents in Modulating the Gut Microbiome and Infant Health. J. Agric. Food Chem. 2022, 70, 3929–3947.
  15. Ding, H.; Yi, X.; Zhang, X.; Wang, H.; Liu, H.; Mou, W.W. Imbalance in the Gut Microbiota of Children with Autism Spectrum Disorders. Front. Cell. Infect. Microbiol. 2021, 11, 496.
  16. Heijtz, R.D.; Wang, S.; Anuar, F.; Qian, Y.; Björkholm, B.; Samuelsson, A.; Hibberd, M.L.; Forssberg, H.; Pettersson, S. Normal Gut Microbiota Modulates Brain Development and Behavior. Proc. Natl. Acad. Sci. USA 2011, 108, 3047–3052.
  17. Hooper, L.V.; Littman, D.R.; Macpherson, A.J. Interactions between the Microbiota and the Immune System. Science (80-) 2012, 336, 1268–1273.
  18. Frye, R.E.; Melnyk, S.; Macfabe, D.F. Unique Acyl-Carnitine Profiles Are Potential Biomarkers for Acquired Mitochondrial Disease in Autism Spectrum Disorder. Transl. Psychiatry 2013, 3, e220.
  19. Slattery, J.; Macfabe, D.F.; Frye, R.E. The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood. Clin. Med. Insights Pediatr. 2016, 10, CMPed.S38338.
  20. Zhang, L.; Xu, Y.; Li, H.; Li, B.; Duan, G.; Zhu, C. The Role of Probiotics in Children with Autism Spectrum Disorders: A Study Protocol for a Randomised Controlled Trial. PLoS ONE 2022, 17, e0263109.
  21. Grenham, S.; Clarke, G.; Cryan, J.F.; Dinan, T.G. Brain-Gut-Microbe Communication in Health and Disease. Front. Physiol. 2011, 2, 94.
  22. Jiang, C.; Li, G.; Huang, P.; Liu, Z.; Zhao, B. The Gut Microbiota and Alzheimer’s Disease. J. Alzheimer’s Dis. 2017, 58, 1–15.
  23. Carabotti, M.; Scirocco, A.; Maselli, M.A.; Severi, C. The Gut-Brain Axis: Interactions between Enteric Microbiota, Central and Enteric Nervous Systems. Ann. Gastroenterol. 2015, 28, 203–209.
  24. Barrett, E.; Ross, R.P.; O’Toole, P.W.; Fitzgerald, G.F.; Stanton, C. γ-Aminobutyric Acid Production by Culturable Bacteria from the Human Intestine. J. Appl. Microbiol. 2012, 113, 411–417.
  25. Serra, D.; Almeida, L.M.; Dinis, T.C.P. Polyphenols in the Management of Brain Disorders: Modulation of the Microbiota-Gut-Brain Axis. Adv. Food Nutr. Res. 2020, 91, 1–27.
  26. Powell, N.; Walker, M.M.; Talley, N.J. The Mucosal Immune System: Master Regulator of Bidirectional Gut–Brain Communications. Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 143–159.
  27. Sun, Q.; Cheng, L.; Zhang, X.; Wu, Z.; Weng, P. The Interaction between Tea Polyphenols and Host Intestinal Microorganisms: An Effective Way to Prevent Psychiatric Disorders. Food Funct. 2021, 12, 952–962.
  28. Argou-Cardozo, I.; Zeidán-Chuliá, F. Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review and Hypothetical Contribution of Environmental Glyphosate Levels. Med. Sci. 2018, 6, 29.
  29. Xu, M.; Xu, X.; Li, J.; Li, F. Association between Gut Microbiota and Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Front. Psychiatry 2019, 10, 473.
  30. Zou, R.; Xu, F.; Wang, Y.; Duan, M.; Guo, M.; Zhang, Q.; Zhao, H.; Zheng, H. Changes in the Gut Microbiota of Children with Autism Spectrum Disorder. Autism Res. 2020, 13, 1614–1625.
  31. De Angelis, M.; Piccolo, M.; Vannini, L.; Siragusa, S.; De Giacomo, A.; Serrazzanetti, D.I.; Cristofori, F.; Guerzoni, M.E.; Gobbetti, M.; Francavilla, R. Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified. PLoS ONE 2013, 8, e76993.
  32. Andreo-Martínez, P.; García-Martínez, N.; Sánchez-Samper, E.P.; Martínez-González, A.E. An Approach to Gut Microbiota Profile in Children with Autism Spectrum Disorder. Environ. Microbiol. Rep. 2020, 12, 115–135.
  33. Tomova, A.; Husarova, V.; Lakatosova, S.; Bakos, J.; Vlkova, B.; Babinska, K.; Ostatnikova, D. Gastrointestinal Microbiota in Children with Autism in Slovakia. Physiol. Behav. 2015, 138, 179–187.
  34. Xie, X.; Li, L.; Wu, X.; Hou, F.; Chen, Y.; Shi, L.; Liu, Q.; Zhu, K.; Jiang, Q.; Feng, Y.; et al. Alteration of the Fecal Microbiota in Chinese Children with Autism Spectrum Disorder. Autism Res. 2022, 15, 996–1007.
  35. Williams, B.L.; Hornig, M.; Buie, T.; Bauman, M.L.; Cho Paik, M.; Wick, I.; Bennett, A.; Jabado, O.; Hirschberg, D.L.; Lipkin, W.I. Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances. PLoS ONE 2011, 6, e24585.
  36. Gondalia, S.V.; Palombo, E.A.; Knowles, S.R.; Cox, S.B.; Meyer, D.; Austin, D.W. Molecular Characterisation of Gastrointestinal Microbiota of Children with Autism (with and without Gastrointestinal Dysfunction) and Their Neurotypical Siblings. Autism Res. 2012, 5, 419–427.
  37. Son, J.S.; Zheng, L.J.; Rowehl, L.M.; Tian, X.; Zhang, Y.; Zhu, W.; Litcher-Kelly, L.; Gadow, K.D.; Gathungu, G.; Robertson, C.E.; et al. Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection. PLoS ONE 2015, 10, e0137725.
  38. Ho, L.K.H.; Tong, V.J.W.; Syn, N.; Nagarajan, N.; Tham, E.H.; Tay, S.K.; Shorey, S.; Tambyah, P.A.; Law, E.C.N. Gut Microbiota Changes in Children with Autism Spectrum Disorder: A Systematic Review. Gut Pathog. 2020, 12, 6.
  39. De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of Diet in Shaping Gut Microbiota Revealed by a Comparative Study in Children from Europe and Rural Africa. Proc. Natl. Acad. Sci. USA 2010, 107, 14691–14696.
  40. Nogay, N.H.; Nahikian-Nelms, M. Can We Reduce Autism-Related Gastrointestinal and Behavior Problems by Gut Microbiota Based Dietary Modulation? A Review. Nutr. Neurosci. 2021, 24, 327–338.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
Video Production Service
Feedback